Thematic Pillars
Thematic Pillars
In alignment with continental priorities and major global funders investing in Africa’s health and biotech ecosystem, APH 2026 will be structured around five strategic pillars, reflecting an all-encompassing breadth across the full spectrum of health products including pharma, biotech, vaccines, diagnostics, medical devices and health supplies.
With a strong full value chain focus, the conference will address the entire health innovation lifecycle—from early-stage research and product development to manufacturing, regulatory approval, distribution, and market access for ensuring sustainable, scalable, and system-wide impact across Africa.
Human Resources
Critical to ensure availability of skilled GMP, R&D, quality, and leadership talent needed to operate, scale, and sustain regional pharma and biotech manufacturing without long-term reliance on external expertise.
Regulatory
Enables in reducing market fragmentation, lower compliance costs, accelerate time-to-market, and enable cross-border manufacturing and clinical development through predictable, harmonized regulatory pathways.
Technical Capacity and Infrastructure
Critical to achieve economies of scale, consistent product quality, and regional production resilience through shared GMP facilities, clinical networks, and enabling R&D and digital infrastructure
Access to Capital
Supporting the capital-intensive nature of pharmaceutical and biotech manufacturing by de-risking investments, enabling technology transfer, and financing facility development and scale-up.
Market Development and Commercial Opportunity
Creating sufficient demand, regional scale, and commercial certainty through integrated markets, pooled procurement, and stronger private sector participation to sustain local manufacturing.
Program Format
APH 2026 will feature a diverse and engaging program format designed to maximize learning, collaboration, and partnership development:
